Dr. Jorge Flores is the Clinical Global Head of the Center for Vaccine Innovation and Access (CVIA) Clinical at PATH. He received his M.D. from the Central University of Venezuela, was a Clinical and Research Fellow at the Massachusetts General Hospital in 1970-1971, and later an Instructor and Assistant Professor of Physiology at Harvard Medical School (1972-1975). From 1975 to 1979 he served on the Microbiology Faculty at the Central University of Venezuela School of Medicine.
Dr. Flores spent over 30 years at the National Institutes of Health (NIH), half of them as a Tenured Senior Scientist at the Laboratory of Infectious Diseases, where he devoted his time to development of rotavirus vaccines, and the other half at the Division of AIDS, where he headed the Clinical HIV vaccine program that supported multiple efforts to develop HIV vaccines. In 2010 Dr. Flores joined PATH and recruited a large clinical team that develops and implements strategies to advance vaccines for rotavirus, influenza, shigella, ETEC, pneumococcus, poliovirus and other pathogens. The work of his team has led / will lead several vaccine candidates through country licensures and prequalification by WHO.